Apotex Takes It On The Chin As Judge Excoriates Chairman For Deceiving PTO
This article was originally published in The Pink Sheet Daily
District judge says Apotex’s Bernard Sherman submitted results of experiments he never conducted to the Patent and Trademark Office; asserts that misconduct in the company’s suit against UCB constitutes an abuse of the patent system.
You may also be interested in...
CooperSurgical is hit with second letter for misleading promotion of its copper-containing intrauterine contraceptive. Video lacked any safety information, agency says in request for corrective communication.
Pfizer and Moderna execs note they have sufficient resources with their partners to meet their vaccine production commitments. J&J, which has a manufacturing arrangement with Sanofi, is ready to ship four million doses of its vaccine upon receiving authorization from FDA.
Pfizer and Genentech execs describe steps they’ve taken to increase diversity in clinical trials from moving trial sites into new neighborhoods to modifying protocols and holding others accountable for diversity.